Get Your Personalized Supplement StackSupplement Stack Quiz

Hydrolyzed Egg Membrane

Also known as: Hydrolyzed Egg Membrane, HEM, Eggshell membrane, natural eggshell membrane, NEM®, hydrolyzed eggshell membrane

Overview

Hydrolyzed Egg Membrane (HEM) is a nutraceutical derived from the thin membrane lining the inside of chicken eggshells. This natural biomaterial is rich in structural proteins, primarily collagen type I, and glycosaminoglycans such as chondroitin sulfate, dermatan sulfate, and hyaluronic acid, which are vital components of human connective tissues. HEM is primarily used as a supplement to support joint health, aiming to reduce pain and stiffness associated with conditions like osteoarthritis. It is also being investigated for its potential benefits in bone health, including the prevention of bone loss. The hydrolysis process enhances the digestibility and bioavailability of its bioactive peptides. While several clinical trials and a systematic review exist, the research maturity is moderate, with a need for more large-scale, placebo-controlled randomized clinical trials to further solidify its efficacy and safety profile.

Benefits

Hydrolyzed Egg Membrane (HEM) offers several evidence-based benefits, primarily for joint and bone health. For joint pain, studies show significant reductions. An open-label study in 44 osteoarthritis patients demonstrated a 22.4% to 35.6% improvement in pain and 27-29% reduction in stiffness within 30 to 60 days of taking 500 mg daily. Two pilot clinical studies also reported 18.4% to 31.3% pain reduction within 7 to 30 days. These effects are considered clinically meaningful, particularly for older adults with osteoarthritis. HEM also shows promise for bone health; a 2024 systematic review highlighted its potential to improve bone mineralization and osteoblast activity, suggesting benefits for osteoporosis prevention, supported by in vitro and pilot clinical data. Secondary benefits include potential anti-inflammatory effects and improved calcium uptake in human cells, which may contribute to overall symptom relief. Benefits can be observed as early as 7-10 days, with continued improvement over 60 days.

How it works

Hydrolyzed Egg Membrane (HEM) works by providing essential structural components and bioactive compounds that support joint and bone health. It supplies collagen type I, a primary protein in connective tissues, and glycosaminoglycans like chondroitin sulfate and hyaluronic acid, which are crucial for cartilage resilience and lubrication. These components are thought to aid in cartilage repair and maintenance. Additionally, HEM may modulate inflammatory cytokines, thereby contributing to its anti-inflammatory effects and pain reduction. The hydrolysis process breaks down the membrane into smaller peptides, improving their absorption and bioavailability, allowing the body to utilize these beneficial compounds more effectively to support the extracellular matrix and overall joint function.

Side effects

Hydrolyzed Egg Membrane (HEM) is generally well tolerated, with clinical studies reporting no serious adverse events. Common side effects (occurring in more than 5% of users) have not been documented in trials. Similarly, uncommon (1-5%) and rare (less than 1%) side effects are not well-documented, with the primary concern being allergic reactions. Individuals with known egg allergies should avoid HEM, as it is derived from eggshells; studies typically exclude participants with egg allergies. There are no documented drug interactions with HEM. Safety during pregnancy and lactation has not been established, so it is advisable for these populations to exercise caution and consult a healthcare professional before use. Overall, HEM has a favorable safety profile for individuals without egg allergies, but further research is needed to fully characterize its safety in broader populations and over longer durations.

Dosage

The recommended and most studied dosage for Hydrolyzed Egg Membrane (HEM) is 500 mg once daily. This dosage has been consistently used in clinical studies and has shown effectiveness in reducing joint pain and stiffness. Benefits typically begin to manifest within 7-10 days of consistent daily supplementation, with continued improvements observed over 60 days. There is no well-established maximum safe dose, but 500 mg daily has been used without adverse effects in trials. The hydrolyzed form of egg membrane is preferred as it enhances the digestibility and absorption of its bioactive components, improving bioavailability. No specific timing considerations (e.g., with or without food) or required cofactors have been identified as critical for its efficacy.

FAQs

Is hydrolyzed egg membrane safe?

Yes, it is generally considered safe and well-tolerated, with no serious adverse effects reported in studies. However, individuals with egg allergies should avoid it.

How soon do benefits appear?

Pain relief and other benefits can begin to appear as early as 7-10 days after starting daily supplementation, with continued improvement over 60 days.

Can it replace conventional osteoarthritis treatments?

Hydrolyzed egg membrane may complement existing osteoarthritis treatments but is not intended to replace standard medical care. Always consult your doctor.

Is it effective for bone health?

Preliminary evidence suggests potential benefits for bone mineralization and osteoblast activity, but more large-scale randomized controlled trials are needed to confirm these effects.

Are there allergy concerns?

Yes, as it is derived from eggs, individuals with a known egg allergy should not use hydrolyzed egg membrane to avoid allergic reactions.

Research Sources

https://www.iomcworld.org/open-access/nem-brand-eggshell-membrane-effective-in-the-treatment-of-pain-associated-with-knee-and-hip-osteoarthritis-results-from--46021.html – This open-label clinical study investigated the efficacy of 500 mg daily NEM® in 44 subjects with knee/hip osteoarthritis. It reported significant reductions in pain and stiffness (up to 35.6% improvement) at 10, 30, and 60 days, with no serious adverse events. The study's limitation is its open-label design and lack of a placebo control.
https://pubmed.ncbi.nlm.nih.gov/38872992/ – This systematic review examined the chemical composition and clinical evidence of eggshell membrane for bone health. It found that ESM components are similar to human bone matrix, supporting mineralization and osteoblast activity. While clinical pilot data showed pain reduction and improved bone markers, the review highlighted the need for larger, more robust randomized controlled trials due to small sample sizes in existing studies.
https://pmc.ncbi.nlm.nih.gov/articles/PMC2697588/ – These two small pilot randomized controlled trials (n=12-26) evaluated NEM® for joint pain. They demonstrated statistically significant pain reduction (18-31%) over 7-30 days with no reported adverse events. The studies were limited by their small sample sizes, short duration, and the exclusion of individuals with egg allergies.
https://onlinelibrary.wiley.com/doi/10.1155/2021/9112010 – This review article discusses the anti-inflammatory properties of eggshell membrane. It suggests that the various components within the eggshell membrane, including collagen and glycosaminoglycans, may contribute to modulating inflammatory pathways, thereby supporting its potential role in alleviating joint discomfort. The article emphasizes the need for further research to fully elucidate the molecular mechanisms behind these anti-inflammatory effects.